Asymmetric antibodies: A protective arm in pregnancy

Chemical Immunology and Allergy

Volumn 89, Issue , 2006, Pages 158-168

  Gutierrez, G ^a   Gentile, T ^a   Miranda, S ^a   Margni, R A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; N ACETYL BETA GLUCOSAMINIDASE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ALLERGY; CELL SURVIVAL; CYTOKINE PRODUCTION; GLYCOSYLATION; HUMAN; IMMUNE RESPONSE; INFECTION; MEDICAL RESEARCH; MICROORGANISM; PHAGOCYTOSIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; TH2 CELL; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; METABOLISM; MOUSE; PLACENTA; TH1 CELL;

ANIMALS; CYTOKINES; FEMALE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; MATERNAL-FETAL EXCHANGE; MICE; MODELS, IMMUNOLOGICAL; PLACENTA; PREGNANCY; TH1 CELLS; TH2 CELLS;

EID: 27244459460     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (36)

1. Margni RA, Binaghi RA: Purification and properties of non-precipitating rabbit antibodies. Immunology 1972;22:557-563.
2. Margni RA, Hajos SE: Biological and physicochemical properties of purified anti-DNP guinea pig non-precipitating antibodies. Immunology 1973;24:435-443.
3. Margni RA, Paz CB, Cordal ME: Immunochemical behavior of sheep non-precipitating antibodies isolated by immunoadsorption. Immunochemistry 1974;11:765-770.
4. Cordal ME, Margni RA: Isolation, purification and biological properties of horse precipitating and non-precipitating antibodies. Immunochemistry 1974;11:765-770.
5. Margni RA, Binaghi RA: Non-precipitating asymmetric antibodies. Annu Rev Immunol 1988;6:534-554.
6. Ronco J, Sciuto E, Leoni J, Margni RA, Binaghi RA: Interaction of purified precipitating and non-precipitating antibodies with hapten and with haptenated protein. Evidence of an asymmetrical antibody molecule. Immunology 1984;52:449-456.
7. Labeta M, Margni RA, Leoni J, Binaghi RA: Structure of asymmetric non-precipitating antibody: Presence of a carbohydrate residue in only one Fab region of the molecule. Immunology 1986;57:311-317.
8. Leoni J, Labeta M, Margni RA: The asymmetric IgG non-precipitating antibody. Localization of the oligosaccharide involved, by Concanavalin A interaction. Mol Immunol 1986;23:1397-1400.
9. Borel IM, Gentile T, Angelucci J, Margni RA, Binaghi RA: Asymmetrically glycosylated IgG isolated from non-immune human sera. Biochim Biophys Acta 1989;990:162-164.
10. Canellada A, Gentile T, Dokmetjian J, Margni RA: Occurrence, properties and function of asymmetric IgG molecules isolated from non-immune sera. Immunol Invest 2002;31:107-120.
11. Margni RA, Malan Borel I: Paradoxical behavior of asymmetric IgG antibodies. Immunol Rev 1998;163:77-87.
12. Margni RA, Perdigón G, Gentile T, Abatángelo C, Dokmetjian J: IgG precipitating and coprecipitating antibodies in rabbits repeatedly injected with soluble and particulate antigens. Vet Immunol Immunopathol 1986;13:51-61.
13. Morelli L, Leoni J, Fossati CA, Margni RA: Symmetric and asymmetric IgG antibodies are synthesized by the same cellular clone. Mol Immunol 1989;26:789-792.
14. Romagnani S, Parronchi P, Delios MM, Romagnani P, Anunziato F, Piccinni MP, Manetti R, Sampog Movilia C, De Carli M, Maggi E, Del Prete GF: An update on human Th1 and Th2 cells. Int Arch Allergy Immunol 1997;113:153-156.
15. Wegmann TG, Lin H, Guilbert L, Mossmann TR: Bidirectional cytokine interactions in the feto-maternal relationship. Is successful pregnancy a Th2 phenomenon? Immunol Today 1993;14:353-356.
16. Voisin G, Chaouat G: Demonstration, nature and properties of maternal antibodies fixed on placenta and directed against paternal alloantigens. J Reprod Fertil 1974;21:89-103.
17. Bell SC, Billington WD: Antifetal alloantibody in the pregnant female. Immunol Rev 1983;75:5-30.
18. Malan Borel I, Gentile T, Angelucci J, Pividori J, Guala MC, Binaghi RA, Margni RA: IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant woman. J Reprod Immunol 1991;20:129-140.
19. Margni RA, Malan Borel I, Kapovic M, Angelucci J, Miranda S, Kinsky R, Chaouat G: The proportion of symmetric and asymmetric IgG antibody molecules synthesized by a cellular clone (hybridoma) can be regulated by placental culture supernatants. Cell Immunol 1992;142:287-295.
20. Gentile T, Margni RA: IgG asymmetric anti-ovalbumin antibodies synthesized by virgin and pregnant rats. J Reprod Immunol 1995;28:1-13.
21. Gutierrez G, Malan Borel I, Margni RA: The placental regulatory factor involved in the asymmetric IgG antibody synthesis responds to IL-6 features. J Reprod Immunol 2001;49:21-32.
22. Gutierrez G, Sarto A, Berod L, Canellada A, Gentile T, Pasqualini S, Margni RA: Regulation of interleukin-6 fetoplacental levels could be involved in the protective effect of low-molecular-weight heparin treatment on murine spontaneous abortion. Am J Reprod Immunol 2004;51:160-165.
23. Zenclussen AC, Gentile T, Kortebani G, Mazzoli A, Margni RA: Asymmetric antibodies and pregnancy. Am J Reprod Immunol 2001;45:289-294.
24. Gentile T, Malan Borel I, Angelucci J, Miranda S, Margni RA: Preferential synthesis of asymmetric antibodies in rats immunized with paternal particulate antigens. Effect on pregnancy. J Reprod Immunol 1992;22:173-183.
25. Zenclussen AC, Roux ME, Margni RA, Malan Borel I: Interleukin-6 in abortion and in normal placentae histological samples. Placenta 1999;20/5/6:A73.
26. Zenclussen AC, Blois S, Stumpo R, Olmos S, Aria K, Malan Borel I, Roux ME, Margni RA: Murine abortion is associated with enhanced interleukin-6 levels at the feto-maternal interface. Cytokine 2003;24:150-160.
27. Canellada A, Farber A, Zenclussen AC, Gentile T, Dokmetjian J, Keil A, Blois S, Miranda S, Berod L, Gutierrez G, Markert UR, Margni RA: Interleukin regulation of asymmetric antibody synthesized by isolated placental B cells. Am J Reprod Immunol 2002;48:275-282.
28. Piccini MP, Guidizi MG, Biagiotti R, Beloni L, Giannarini F, Livi C, Romagnani S, Maggi E: Progesterone favors the development of human T helper cells producing Th2 type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995;155:128-133.
29. Lim KJH, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID: Profile of cytokine mRNA expression in peri-implantation human endometrium. Mol Hum Reprod 1998;4:77-81.
30. Kelemen K, Bognar I, Paal M, Szekeres-Bartho J: A progesterone-induced protein increases the synthesis of asymmetric antibodies. Cell Immunol 1996;167:129-134.
31. Chaouat G: Cytokine networks at the feto-maternal interface: Are the existing paradigms still valid? (abstract MS2-1). Am J Reprod Immunol 2001;46:25.
32. Croy BA: Where now for the Th1/Th2 paradigm of the gestational uterus? J Reprod Immunol 2001;51:1-2.
33. Arck PC, Zenclussen AC, Fest S, Sehmsdorf US, Klapp BF: Challenging the Th1/Th2 dichotomy. Am J Reprod Immunol 2001;45:P11.
34. Miranda S, Canellada A, Gentile T, Margni R: Interleukin-6 and dexamethasone modulate in vitro asymmetric antibody synthesis and UDP-Glc glycoprotien glycosyltransferase activity. J Reprod Immunol, in press.
35. Miranda S, Gentile T, Margni RA: Enhancement of in vitro hsp 72 expression by placental IL-6. Am J Reprod Immunol 2001;46:358-365.
36. Margni RA, Zenclussen AC: During pregnancy in the context of a Th2-type cytokine profile, serum IL-6 levels might condition the quality of the synthesized antibodies. Am J Reprod Immunol 2001;46:181-187.